Trial Status: Recruiting Clinical Trials Identifier: NCT06797869 Trial Name: A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy Diabetes Type: Type 2 diabetes Trial Sponsor: Novo Nordisk A/S Why is this study important
The glucagon component increases energy expenditure and fat oxidation, a mechanism unique to retatrutide that semaglutide (GLP-1 only) and tirzepatide (GLP-1/GIP) lack
Researchers also note that these side effects may be more likely to affect people who already have a mental health diagnosis
Interestingly, in a retrospective study of 186 patients (56% type 1 diabetes mellitus) from the Netherlands, dyspeptic symptoms, with the exception of early satiety and abdominal pain, were unrelated to delayed gastric emptying [69]
Med Sci Sports Exerc 16(4):328338 Qin Q-F, Liu M, Tian G-H, Chen J, Li Y-S (2018) Extract of the blood circulation-promoting recipe-84 can protect rat retinas by inhibiting the -catenin signaling pathway
En tercer lugar, y esto tambin ayudar con el estreimiento: busquen asesoramiento nutricional